The strategic involvement of IRS in cancer progression
Authors:
- 16 September 2023
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 680, 141-160
Abstract
No abstract availableKeywords
This publication has 152 references indexed in Scilit:
- Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor MaintenanceCancer Cell, 2013
- Insulin Receptor Substrate 2 Is Required for Testicular DevelopmentPLOS ONE, 2013
- O-GlcNAc signaling: a metabolic link between diabetes and cancer?Trends in Biochemical Sciences, 2010
- ERK2 but Not ERK1 Induces Epithelial-to-Mesenchymal Transformation via DEF Motif-Dependent Signaling EventsMolecular Cell, 2010
- Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growthNature Medicine, 2010
- IRS1 Regulation by Wnt/β-Catenin Signaling and Varied Contribution of IRS1 to the Neoplastic PhenotypeJournal of Biological Chemistry, 2010
- SirT1 Inhibition Reduces IGF-I/IRS-2/Ras/ERK1/2 Signaling and Protects NeuronsCell Metabolism, 2008
- Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substratesProceedings of the National Academy of Sciences, 2006
- The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolismNature Reviews Genetics, 2006
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006